Litcius/Paper detail

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study

Jiřı́ Beran, Humberto Reynales, Airi Põder, Charles Yu, Punnee Pitisuttithum, Lee Li Yuan, Wim Vermeulen, Carole Verhoeven, Brett Leav, Bin Zhang, Daphne Sawlwin, Esther Hamers-Heijnen, Jonathan M. Edelman, Igor Smolenov

2021The Lancet Infectious Diseases48 citationsDOI

Topics & Concepts

MedicineInfluenza vaccineVaccine efficacyHazard ratioClinical endpointPopulationVaccinationProportional hazards modelLive attenuated influenza vaccineYoung adultClinical trialInternal medicineImmunologyConfidence intervalEnvironmental healthInfluenza Virus Research StudiesRespiratory viral infections researchImmune responses and vaccinations
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study | Litcius